Yatin Suneja
Stock Analyst at Guggenheim
Total Price Targets
23
Stocks Covered
15
Sectors
Healthcare
Most Recent
Mar 9, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Yatin Suneja
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | $90.00 | $56.81 | +58.4% | 1 | Mar 9, 2026 |
| SION | Sionna Therapeutics, Inc. | $50.00 | $39.33 | +27.1% | 1 | Mar 2, 2026 |
| BIIB | Biogen Inc. | $246.00 | $186.69 | +31.8% | 3 | Feb 9, 2026 |
| STOK | Stoke Therapeutics, Inc. | $60.00 | $33.22 | +80.6% | 1 | Feb 5, 2026 |
| ALMS | Alumis Inc. Common Stock | $32.00 | $25.27 | +26.6% | 1 | Jan 7, 2026 |
| AXSM | Axsome Therapeutics, Inc. | $205.00 | $204.09 | +0.4% | 2 | Jan 2, 2026 |
| IMVT | Immunovant, Inc. | $41.00 | $27.11 | +51.2% | 2 | Dec 18, 2025 |
| DBVT | DBV Technologies S.A. | $51.00 | $20.11 | +153.6% | 1 | Dec 17, 2025 |
| PRAX | Praxis Precision Medicines, Inc. | $760.00 | $330.59 | +129.9% | 3 | Dec 9, 2025 |
| PHAT | Phathom Pharmaceuticals, Inc. | $20.00 | $11.73 | +70.5% | 1 | Oct 30, 2025 |
| DNTH | Dianthus Therapeutics, Inc. | $100.00 | $87.86 | +13.8% | 1 | Sep 8, 2025 |
| ANAB | AnaptysBio, Inc. | $54.00 | $66.67 | -19.0% | 2 | May 6, 2025 |
| ACAD | ACADIA Pharmaceuticals Inc. | $20.00 | $21.95 | -8.9% | 2 | Jan 3, 2025 |
| ZURA | Zura Bio Limited | $15.00 | $5.21 | +187.9% | 1 | Nov 8, 2024 |
| REGN | Regeneron Pharmaceuticals, Inc. | $1180.00 | $703.72 | +67.7% | 1 | Jul 18, 2024 |
Recent Activity
- Mar 9, 2026— Set$90.00price target onXENE(Xenon Pharmaceuticals Inc.)
- Mar 2, 2026— Set$50.00price target onSION(Sionna Therapeutics, Inc.)
- Feb 9, 2026— Set$246.00price target onBIIB(Biogen Inc.)
- Feb 5, 2026— Set$60.00price target onSTOK(Stoke Therapeutics, Inc.)
- Jan 7, 2026— Set$32.00price target onALMS(Alumis Inc. Common Stock)
- Jan 2, 2026— Set$205.00price target onAXSM(Axsome Therapeutics, Inc.)
- Dec 18, 2025— Set$41.00price target onIMVT(Immunovant, Inc.)
- Dec 17, 2025— Set$51.00price target onDBVT(DBV Technologies S.A.)
- Dec 9, 2025— Set$760.00price target onPRAX(Praxis Precision Medicines, Inc.)
- Nov 6, 2025— Set$540.00price target onPRAX(Praxis Precision Medicines, Inc.)
- Oct 30, 2025— Set$20.00price target onPHAT(Phathom Pharmaceuticals, Inc.)
- Sep 8, 2025— Set$100.00price target onDNTH(Dianthus Therapeutics, Inc.)
- May 6, 2025— Set$54.00price target onANAB(AnaptysBio, Inc.)
- Jan 3, 2025— Set$20.00price target onACAD(ACADIA Pharmaceuticals Inc.)
- Nov 12, 2024— Set$135.00price target onAXSM(Axsome Therapeutics, Inc.)
- Nov 8, 2024— Set$15.00price target onZURA(Zura Bio Limited)
- Oct 21, 2024— Set$90.00price target onANAB(AnaptysBio, Inc.)
- Aug 14, 2024— Set$85.43price target onPRAX(Praxis Precision Medicines, Inc.)
- Jul 18, 2024— Set$1180.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- May 30, 2024— Set$48.00price target onIMVT(Immunovant, Inc.)
Frequently Asked Questions
Who is Yatin Suneja?
Yatin Suneja is a stock analyst at Guggenheim covering 15 stocks primarily in Healthcare. They have issued 23 price targets since Dec 21, 2021.
What stocks does Yatin Suneja cover?
Yatin Suneja currently covers 15 stocks, including BIIB, PRAX, AXSM, IMVT, ANAB.
What is Yatin Suneja's latest price target?
Yatin Suneja's most recent price target was $90.00 on XENE (Xenon Pharmaceuticals Inc.), set on Mar 9, 2026.
What is Yatin Suneja's highest price target?
Yatin Suneja's highest issued price target is $1180.00 on REGN, set on Jul 18, 2024.
More Analysts at Guggenheim
Coverage based on publicly published price targets. Not investment advice.